Dr. Robert Miller, who directs MDA's ALS center at California Pacific Medical Center in San Francisco, will coordinate the study. The drug and placebo will be given orally. After the twelve-month study, everyone who wishes to receive Neurontin for the next six months can do so. You should be prepared to visit your center every four weeks for twelve months and then at one, three and six months after that. Each visit will last about 1 hour and 15 minutes, except for the first visit, which will be longer.
Participation is cost free to patients.
Please speak to Cathy or Karen.